| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/09/2005 | EP1280805B1 Novel imidazotriazinones and the use thereof |
| 02/09/2005 | EP1280525B1 Methods and compositions for modulating alpha adrenergic receptor activity |
| 02/09/2005 | EP1223927B1 Use of retigabin for treating neuropathic pain |
| 02/09/2005 | EP1191924A4 Pharmaceutical dosage form for pulsatile delivery of (d-threo)-methylphenidate and a second cns stimulant |
| 02/09/2005 | EP1181024B1 Use of glycosaminoglycans for the treatment of senile dementia |
| 02/09/2005 | EP1165054A4 Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
| 02/09/2005 | EP1150960B1 Polymorphic crystalline forms of celecoxib |
| 02/09/2005 | EP1140939B1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidines, and related pharmaceutical compositions and methods |
| 02/09/2005 | EP1117399B1 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
| 02/09/2005 | EP1071417B1 Use of cannabidiol as anti-inflammatory agent |
| 02/09/2005 | EP1044202B1 1'- 4- 1- (4-fluorophenyl)- 1h-indole-3-yl] -1-butyl]-spiro isobenzofuran- 1(3h),4'- piperidine] hydrohalogenides |
| 02/09/2005 | EP1042316B1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 02/09/2005 | EP0941093B1 Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety |
| 02/09/2005 | EP0700438B1 Opioid receptors: compositions and methods |
| 02/09/2005 | CN1578838A Method and means for producing protein with prospective post-translation modification |
| 02/09/2005 | CN1578786A Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/09/2005 | CN1578785A Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 02/09/2005 | CN1578782A Silicon compounds |
| 02/09/2005 | CN1578779A Small organic molecule regulators of cell proliferation |
| 02/09/2005 | CN1578778A Tetrahydropyran derivatives and their use as therapeutic agents |
| 02/09/2005 | CN1578772A Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2005 | CN1578665A Type 4 phosphodiesterase inhibitors and uses thereof |
| 02/09/2005 | CN1578664A Depot formulations of iloperidone and a star polymer |
| 02/09/2005 | CN1578662A Pyridine derivatives as nmda-receptor subtype blockers |
| 02/09/2005 | CN1578661A Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
| 02/09/2005 | CN1575818A Genetic medicine for preventing or curing parkinson's disease, depression and treatment of giving up drugs |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1575810A Chinese herbal medicine for treating intractable headache |
| 02/09/2005 | CN1188428C 6-mercapto-cyclodextrin derivs medical composition containing the same derivs and use thereof |
| 02/09/2005 | CN1188416C Oxathiepino [6,5-b]dihydropyridines,and related compositions and preparation methods |
| 02/09/2005 | CN1188413C Compound for treatment of pain |
| 02/09/2005 | CN1188412C Process for preparing crystalline form 1 of cabergoline |
| 02/09/2005 | CN1188405C New Morpholinobenzamide salts |
| 02/09/2005 | CN1188404C Cyclic compound |
| 02/09/2005 | CN1188403C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/09/2005 | CN1188165C Method for treating pain by peripheral administration of neurotoxin |
| 02/09/2005 | CN1188164C Compositions and method for regulating phagocytosis and ICAM-1 expression |
| 02/09/2005 | CN1188146C Drug-dropping snuff with Chinese medicine |
| 02/09/2005 | CN1188141C Use of ginkgo biloba extracts for preparing a medicine |
| 02/09/2005 | CN1188140C Reduction of oxidative stress factors |
| 02/09/2005 | CN1188135C Nutrient tablet for sobering and protecting liver |
| 02/09/2005 | CN1188131C Orally taken pulsed releasing system of phenyl diazepine medicine and its prepn |
| 02/09/2005 | CN1188130C Quetiapine granules |
| 02/09/2005 | CN1188128C Triazineone compounds for treating diseases due to sarcosystis neospora and toxoplasma |
| 02/09/2005 | CN1188123C Novel use of (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylamino methyl]-benzodihydropyran and its physiologically acceptable salts |
| 02/09/2005 | CN1188121C Therapeutic substituted guanidines |
| 02/09/2005 | CN1188120C Method for treating eating disorders |
| 02/09/2005 | CN1188111C Dry powder compositions having improved dispersivity |
| 02/09/2005 | CN1188070C Filling material of natural flower fragrance health pillow |
| 02/09/2005 | CN1188055C Composition |
| 02/08/2005 | US6852889 Antioxidant nitroxides and nitrones as therapeutic agents |
| 02/08/2005 | US6852870 Omega-3 fatty acids in the treatment of depression |
| 02/08/2005 | US6852858 Dissolving in solvents; precipitation; isolation; sleep disorders |
| 02/08/2005 | US6852751 Difluorobutyric acid metalloprotease inhibitors |
| 02/08/2005 | US6852749 Pyrazolidinol compounds |
| 02/08/2005 | US6852743 Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof |
| 02/08/2005 | US6852738 Potent ligands for PPAR gamma and generally have antagonist or partial agonist activity. The compoundsare for treatment, control or prevention of obesity, non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, |
| 02/08/2005 | US6852736 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 02/08/2005 | US6852732 A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula (I): has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. (Corticotropin releasing factor |
| 02/08/2005 | US6852730 Substituted fused pyrazolecarboxylic acid arylamides and related compounds |
| 02/08/2005 | US6852726 Such as 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)-3-methanesulfonyl-2-methyl-1H-indole for preventing/treating disorders modulated by alpha-1A/L adrenoceptors such as urinary incontinence and sexual disorders |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852721 Compounds capable of activating nicotinic cholinergic receptors; N-aryl diazabicyclic compounds such as (1S,4S)-2-(5-(3-methoxyphenoxy)-3-pyridyl)-2,5-diazabicyclo(2. 2.1)-heptane; treating central nervous system disorders |
| 02/08/2005 | US6852720 Thiazol-2-yl-imine compounds as PDE-7 inhibitors |
| 02/08/2005 | US6852719 Glucocorticoid receptor modulators |
| 02/08/2005 | US6852718 Selective 5-HT2A antagonists useful in treatment or prevention of CNS conditions |
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 02/08/2005 | US6852716 Central nervous system disorders; psychological disorders |
| 02/08/2005 | US6852700 Colostrinin, and uses thereof |
| 02/08/2005 | US6852533 For making vectors for gene therapy |
| 02/08/2005 | US6852333 Agents and methods for promoting production gains in animals |
| 02/08/2005 | CA2112081C Imidazole compounds, their preparation and use |
| 02/08/2005 | CA2097208C The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |
| 02/03/2005 | WO2005009999A1 Process for producing imide compound |
| 02/03/2005 | WO2005009996A1 Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 02/03/2005 | WO2005009992A1 Cyclohexanecarboxylic acid compound |
| 02/03/2005 | WO2005009977A1 Substituted pyrimidin-4-ylamina analogues as vanilloid receptor ligands |
| 02/03/2005 | WO2005009974A1 Imidazole compounds and uses thereof |
| 02/03/2005 | WO2005009941A1 Indane derivates as muscarinic receptor agonists |
| 02/03/2005 | WO2005009540A1 Perinatal hypoxic-ischemic brain damage treatment |
| 02/03/2005 | WO2005009445A1 A1 adenosine receptor antagonists |
| 02/03/2005 | WO2005009444A1 Medicinal compositions |
| 02/03/2005 | WO2005009442A1 Nasal pharmaceutical composition of piribedil |
| 02/03/2005 | WO2005009425A1 Substituted 2-aminotetralin for the treatment of depression |
| 02/03/2005 | WO2005009343A2 A1 adenosine receptor antogonists |
| 02/03/2005 | WO2004101565A3 Jnk inhibitors |
| 02/03/2005 | WO2004094384A3 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease |
| 02/03/2005 | WO2003063779A3 Selective analgesic agents |
| 02/03/2005 | WO2003062390A3 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
| 02/03/2005 | WO2003039342A3 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145 |
| 02/03/2005 | WO2003015691A3 RAPID IMPROVEMENT OF COGNITION IN CONDITIONS RELATED TO A$g(b) |
| 02/03/2005 | WO2002096360A3 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 02/03/2005 | US20050027125 Intensifiers of adenosine receptors for cardiac arrhythmia |
| 02/03/2005 | US20050027121 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases |
| 02/03/2005 | US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 02/03/2005 | US20050027103 Matrix protein for use diagnosis, treatment, and prevention of viral infections, cell proliferative and neurological disorders |
| 02/03/2005 | US20050027014 And other diseases such as Down's syndrome related to A beta peptide, a component of amyloid plaques; inhibitors of the beta-secretase enzyme |
| 02/03/2005 | US20050027009 New derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |